Pericarditis Clinical Trial
Official title:
Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The ICAP Trial: Investigation on Colchicine for Acute Pericarditis
The purpose of the study is to determine whether colchicine is safe and effective in the treatment of acute pericarditis and the prevention of subsequent recurrences.
Colchicine is safe and effective in the management of recurrent pericarditis after failure
of conventional treatment. Preliminary data have shown that it may be effective also in
treatment of the index attack of pericarditis and the prevention of further recurrences.
Comparisons: The study will compare the safety and efficacy of colchicine in the treatment
of acute pericarditis and the primary prevention of recurrences. Colchicine will be used in
addition to conventional treatment.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03253315 -
Management of Pericarditis in Children.
|
N/A | |
Recruiting |
NCT02754713 -
Prognostic Biomarkers in Patients With Acute Pericarditis
|
N/A | |
Completed |
NCT00235079 -
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.
|
Phase 4 | |
Completed |
NCT04906720 -
Post-Ablation Pericarditis Reduction Study
|
Phase 2 | |
Not yet recruiting |
NCT05805930 -
Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children
|
Phase 3 | |
Not yet recruiting |
NCT06411340 -
Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
|
||
Terminated |
NCT00946907 -
Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin
|
Phase 4 | |
Not yet recruiting |
NCT05925790 -
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
|
||
Recruiting |
NCT04294771 -
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
|
||
Enrolling by invitation |
NCT04774549 -
Inflammatory Cardiomyopathy Bern Registry
|
||
Completed |
NCT02083510 -
Apolipoprotein CIII Reduction Via Colchicine
|
Phase 0 | |
Enrolling by invitation |
NCT01063582 -
Noise, a Risk for Heart in Airplane Pilots
|
N/A | |
Completed |
NCT04692766 -
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03231449 -
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
|
||
Completed |
NCT00128414 -
Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)
|
Phase 3 | |
Recruiting |
NCT05046002 -
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
|
||
Recruiting |
NCT06103123 -
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
|
||
Completed |
NCT01395082 -
ACAM2000® Myopericarditis Registry
|